Overview
Bardia Nourbakhsh, M.D., M.A.S., is an associate professor of neurology at Johns Hopkins University School of Medicine. He practices out of The Johns Hopkins Hospital in Baltimore, Maryland. Dr. Nourbakhsh has expertise in multiple sclerosis (MS) and neuroimmunology. Dr. Nourbakhsh earned his medical degree from the Tehran University School of Medical Sciences and completed a residency in neurology at the University of Texas Southwestern Medical Center. He studied epidemiology, study design, and biostatistics, obtaining a Master of Advanced Studies degree in clinical research from the University of California, San Francisco School of Medicine, where he also completed a fellowship in MS and neuroimmunology. In 2014, Dr. Nourbakhsh earned the American Brain Foundation Clinical Research Training Fellowship in MS, the National Multiple Sclerosis Society Sylvia Lawry Clinical Research Fellowship, the Fred Baskin Young Investigator Award, and the Teva Neuroscience Award for Academic Excellence. In 2022, he was named a Harry Weaver Neuroscience Scholar by the National Multiple Sclerosis Society. Dr. Nourbakhsh's research training focused on the design and execution of clinical trials and the use of biomarkers in MS. His current research interests include the comparative effectiveness studies of symptomatic and disease-modifying therapies in MS, as well as identifying new pathophysiologic mechanisms and therapeutic targets for MS-related fatigue. Dr. Nourbakhsh is the principal investigator of a randomized, double-blind clinical trial funded by the Department of Defense, which tests whether ketamine could be a treatment for MS fatigue. He has contributed to numerous publications, journal articles, abstracts and posters, and lectures. He is an ad hoc reviewer for Lancet Neurology, Annals of Neurology, Neurology, Neurology: Neuroimmunology and Neuroinflammation, Multiple Sclerosis Journal, and other journals.
Dr. Nourbakhsh is rated as an Experienced provider by MediFind in the treatment of Optic Neuritis. His top areas of expertise are Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, and Meningocele.
His clinical research consists of co-authoring 66 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Optic Neuritis.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Floor 5, Baltimore, MD 21287
7315 Wisconsin Avenue, Suite 700, Bethesda, MD 20814
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Johns Hopkins University
Peter Calabresi is a Neurologist in Baltimore, Maryland. Dr. Calabresi is rated as an Elite provider by MediFind in the treatment of Optic Neuritis. His top areas of expertise are Multiple Sclerosis (MS), Optic Neuritis, Relapsing Multiple Sclerosis (RMS), and CACH Syndrome.
Johns Hopkins Outpatient Center
Elias Sotirchos, M.D., specializes in the diagnosis, management and treatment of neuroimmunological disorders that involve the central nervous system, including multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). His research focuses on developing and validating novel imaging and blood-based biomarkers of these conditions, and clinical trials of experimental therapeutic agents. Dr. Sotirchos earned his medical degree from the National and Kapodistrian University of Athens and subsequently completed his internship and neurology residency training at The Johns Hopkins Hospital. He then pursued advanced clinical and research training in neuroimmunology at Johns Hopkins as a National MS Society Sylvia Lawry Fellow. Dr. Sotirchos is rated as a Distinguished provider by MediFind in the treatment of Optic Neuritis. His top areas of expertise are Optic Neuritis, Multiple Sclerosis (MS), Neuromyelitis Optica, and Transverse Myelitis.
Johns Hopkins University
Shiv Saidha is a Neurologist in Baltimore, Maryland. Dr. Saidha is rated as a Distinguished provider by MediFind in the treatment of Optic Neuritis. His top areas of expertise are Multiple Sclerosis (MS), Optic Neuritis, Relapsing Multiple Sclerosis (RMS), and Stiff Person Syndrome. Dr. Saidha is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Multiple Sclerosis (MS)Dr. Nourbakhsh isElite. Learn about Multiple Sclerosis (MS).
- Distinguished
- Relapsing Multiple Sclerosis (RMS)Dr. Nourbakhsh isDistinguished. Learn about Relapsing Multiple Sclerosis (RMS).
- Advanced
- Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
- Experienced
- Arteriovenous MalformationDr. Nourbakhsh isExperienced. Learn about Arteriovenous Malformation.
- Brown SyndromeDr. Nourbakhsh isExperienced. Learn about Brown Syndrome.
- CACH SyndromeDr. Nourbakhsh isExperienced. Learn about CACH Syndrome.
- MeningoceleDr. Nourbakhsh isExperienced. Learn about Meningocele.
- Neuromyelitis OpticaDr. Nourbakhsh isExperienced. Learn about Neuromyelitis Optica.
- Optic NeuritisDr. Nourbakhsh isExperienced. Learn about Optic Neuritis.